Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial

• Published in: PLoS medicine 2011-02, Vol.8 (2), p.e1000407-e1000407
• Main Authors: Dicko, Alassane, Diallo, Abdoulbaki I, Tembine, Intimbeye, Dicko, Yahia, Dara, Niawanlou, Sidibe, Youssoufa, Santara, Gaoussou, Diawara, Halimatou, Conaré, Toumani, Djimde, Abdoulaye, Chandramohan, Daniel, Cousens, Simon, Milligan, Paul J, Diallo, Diadier A, Doumbo, Ogobara K, Greenwood, Brian
• Format: Article
• Language: English
• Subjects: Biological anthropology; Child, Preschool; Children; Children & youth; Confidence intervals; Double-Blind Method; Female; Fever in children; Health aspects; Health facilities; Human health and pathology; Humanities and Social Sciences; Humans; Infant; Infections; Infectious diseases; Insecticide-Treated Bednets; Insecticides; Intervention; Life Sciences; Malaria; Malaria - prevention & control; Malaria - transmission; Male; Mali; Medicine, Preventive; Morbidity; Placebos; Prevention; Preventive health services; Public Health and Epidemiology/Infectious Diseases; Quality control; Risk factors; Santé publique et épidémiologie; Seasons
• ISSN: 1549-1676; 1549-1277; 1549-1676
• DOI: 10.1371/journal.pmed.1000407

Previous studies have shown that in areas of seasonal malaria transmission, intermittent preventive treatment of malaria in children (IPTc), targeting the transmission season, reduces the incidence of clinical malaria. However, these studies were conducted in communities with low coverage with insecticide-treated nets (ITNs). Whether IPTc provides additional protection to children sleeping under an ITN has not been established. To assess whether IPTc provides additional protection to children sleeping under an ITN, we conducted a randomised, double-blind, placebo-controlled trial of IPTc with sulphadoxine pyrimethamine (SP) plus amodiaquine (AQ) in three localities in Kati, Mali. After screening, eligible children aged 3-59 mo were given a long-lasting insecticide-treated net (LLIN) and randomised to receive three rounds of active drugs or placebos. Treatments were administered under observation at monthly intervals during the high malaria transmission season in August, September, and October 2008. Adverse events were monitored immediately after the administration of each course of IPTc and throughout the follow-up period. The primary endpoint was clinical episodes of malaria recorded through passive surveillance by study clinicians available at all times during the follow-up. Cross-sectional surveys were conducted in 150 randomly selected children weekly and in all children at the end of the malaria transmission season to assess usage of ITNs and the impact of IPTc on the prevalence of malaria, anaemia, and malnutrition. Cox regression was used to compare incidence rates between intervention and control arms. The effects of IPTc on the prevalence of malaria infection and anaemia were estimated using logistic regression. 3,065 children were screened and 3,017 (1,508 in the control and 1,509 in the intervention arm) were enrolled in the study. 1,485 children (98.5%) in the control arm and 1,481 (98.1%) in the intervention arm completed follow-up. During the intervention period, the proportion of children reported to have slept under an ITN was 99.7% in the control and 99.3% in intervention arm (p = 0.45). A total of 672 episodes of clinical malaria defined as fever or a history of fever and the presence of at least 5,000 asexual forms of Plasmodium falciparum per microlitre (incidence rate of 1.90; 95% confidence interval [CI] 1.76-2.05 episodes per person year) were observed in the control arm versus 126 (incidence rate of 0.34; 95% CI 0.29-0.41 episodes p